Literature DB >> 11385965

Autoimmune liver disease. Current standards, future directions.

R G Gish1, A Mason.   

Abstract

The diagnosis and management of autoimmune hepatitis continues to evolve as new diagnostic tests and new therapies are added to the armamentarium. Also encouraging are the advances in the understanding of the human immune system and its involvement in the origin and course of auto immune diseases in general and in the variants of autoimmune liver disease. Promising changes are expected in the next few years as new medications become available to the practicing hepatologist. New immune tests may allow therapies to be customized to patients, and antiviral therapies may also eventually be used in the management of this autoimmune liver diseases.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11385965     DOI： 10.1016/s1089-3261(05)70167-7

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN： 1089-3261            Impact factor:   6.126


  10 in total

1.  Relationship between autoimmune hepatitis and HLA-DR4 and DRbeta allelic sequences in the third hypervariable region in Chinese.

Authors:  X Ma; D K Qiu
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

Review 2.  Combination antiretroviral studies for patients with primary biliary cirrhosis.

Authors:  Ellina Lytvyak; Aldo J Montano-Loza; Andrew L Mason
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 3.  Controversies in liver biopsy: who, where, when, how, why?

Authors:  Lawrence S Friedman
Journal:  Curr Gastroenterol Rep       Date:  2004-02

Review 4.  Recognizing immunoglobulin G4 related overlap syndromes in patients with pancreatic and hepatobiliary diseases.

Authors:  Aldo J Montano-Loza; Eoin Lalor; Andrew L Mason
Journal:  Can J Gastroenterol       Date:  2008-10       Impact factor: 3.522

5.  Frequent proviral integration of the human betaretrovirus in biliary epithelium of patients with autoimmune and idiopathic liver disease.

Authors:  W Wang; S Indik; S T Wasilenko; A Faschinger; E J Carpenter; Z Tian; Y Zhang; G K-S Wong; A L Mason
Journal:  Aliment Pharmacol Ther       Date:  2014-12-18       Impact factor: 8.171

6.  Clinical Profile and HLA Typing of Autoimmune Hepatitis From Pakistan.

Authors:  Nasir Hassan; Adeelur Rehman Siddiqui; Zaigham Abbas; Syed Mujahid Hassan; Ghous Bux Soomro; Muhammed Mubarak; Sabiha Anis; Rana Muzaffar; Mirza Naqi Zafar
Journal:  Hepat Mon       Date:  2013-12-16       Impact factor: 0.660

Review 7.  Linking Human Betaretrovirus with Autoimmunity and Liver Disease in Patients with Primary Biliary Cholangitis.

Authors:  Hussain Syed; Tara Penner; Andrew L Mason
Journal:  Viruses       Date:  2022-08-31       Impact factor: 5.818

8.  Identification of hepatotropic viruses from plasma using deep sequencing: a next generation diagnostic tool.

Authors:  John Law; Juan Jovel; Jordan Patterson; Glenn Ford; Sandra O'keefe; Weiwei Wang; Bo Meng; Deyong Song; Yong Zhang; Zhijian Tian; Shawn T Wasilenko; Mandana Rahbari; Troy Mitchell; Tracy Jordan; Eric Carpenter; Andrew L Mason; Gane Ka-Shu Wong
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

Review 9.  Is there a role for cyclophilin inhibitors in the management of primary biliary cirrhosis?

Authors:  Shawn T Wasilenko; Aldo J Montano-Loza; Andrew L Mason
Journal:  Viruses       Date:  2013-01-24       Impact factor: 5.048

Review 10.  Apples to Apples? A Comparison of Real-World Tolerability of Antiretrovirals in Patients with Human Immunodeficiency Virus Infection and Patients with Primary Biliary Cholangitis.

Authors:  Shannon L Turvey; Lynora Saxinger; Andrew L Mason
Journal:  Viruses       Date:  2022-03-03       Impact factor: 5.048
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.